[
  {
    "ts": null,
    "headline": "Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today",
    "summary": "Vertex Pharmaceuticals (VRTX) closed at $468.09 in the latest trading session, marking a +0.94% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=1218bedb10e55b2e2309701cbab8953eac4753d44f0ea1745b42aefa4f3d4d9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734389413,
      "headline": "Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today",
      "id": 132018202,
      "image": "https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) closed at $468.09 in the latest trading session, marking a +0.94% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=1218bedb10e55b2e2309701cbab8953eac4753d44f0ea1745b42aefa4f3d4d9e"
    }
  },
  {
    "ts": null,
    "headline": "BMY vs. VRTX: Which Stock Is the Better Value Option?",
    "summary": "BMY vs. VRTX: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=601c81d4ab784ce299905448dd9d0933fa1d5eddf74fb6cbd60422320ac09047",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734367213,
      "headline": "BMY vs. VRTX: Which Stock Is the Better Value Option?",
      "id": 132014599,
      "image": "https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "BMY vs. VRTX: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=601c81d4ab784ce299905448dd9d0933fa1d5eddf74fb6cbd60422320ac09047"
    }
  },
  {
    "ts": null,
    "headline": "Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030",
    "summary": "Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason.  Drugmakers often see phases of growth as they develop candidates for a high-potential treatment area or as they launch promising new products.  Over time, you can benefit from these periods by buying shares of certain biotech and pharma companies and holding for the long term.",
    "url": "https://finnhub.io/api/news?id=f0a39cb13100310ee4ceab8e3c3544501ca9f7560b8c890e4e0106b8fc0c9210",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734340500,
      "headline": "Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030",
      "id": 132009839,
      "image": "https://g.foolcdn.com/editorial/images/801046/gettyimages-1272759382.jpg",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason.  Drugmakers often see phases of growth as they develop candidates for a high-potential treatment area or as they launch promising new products.  Over time, you can benefit from these periods by buying shares of certain biotech and pharma companies and holding for the long term.",
      "url": "https://finnhub.io/api/news?id=f0a39cb13100310ee4ceab8e3c3544501ca9f7560b8c890e4e0106b8fc0c9210"
    }
  }
]